2 completed, 1 not yet recruiting. 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Aripiprazole Augmentation: new trials by email Literature Review of Aripiprazole Augmentation trials Research Report on Aripiprazole Augmentation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The BAARD Study : Evaluating a Computerized Approach to Treatment Selection in Older Adults With Treatment Resistant Depression. Aripiprazole Augmentation, Bupropion Augmentation - Late Life Treatment Resistant Depression, Depression - Major Depressive Disorder | Phase 2 | Not yet recruiting | Washington University School of Medicine | 300 | 2026-10-01 | 2026-10-16 |
| RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion - Depression, Dementia | Phase 4 | Completed | Centre for Addiction and Mental Health | 87 | 2019-08-01 | 2024-11-25 |
| Optimizing Outcomes of Treatment-Resistant Depression in Older Adults Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion - Treatment Resistant Depression, Major Depressive Disorder | Phase 4 | Completed | Washington University School of Medicine | 742 | 2017-02-24 | 2024-10-03 |
Depressive Disorder, Treatment-Resistant (3) · Depressive Disorder, Major (2) · Cognitive Dysfunction (1) · Dementia (1) · Depression (1)
Washington University School of Medicine (2) · Centre for Addiction and Mental Health (1)
Canada (3) · United States (3)
Aristotle Voineskos, MD (1) · Eric Lenze, MD (1) · Ginger E Nicol (1)
PMID 36867173, PMID 38822571, PMID 41237789
1UG3MH137353-01 (1), R01MH114966 (1), R01MH114970 (1), R01MH114980 (1), R01MH114981 (1)